By the Doktorly editorial team · Medically reviewed by the Doktorly medical team · Last updated: 6 November 2026
Ozempic has become one of the most talked-about drug names in the world – even though the injection is not officially approved for weight loss. Many people are surprised to learn that Ozempic is, in fact, a type 2 diabetes medication. The headline weight-loss results come from a different approval of the same active ingredient: Wegovy.
This page explains how Ozempic works, how the dosing schedule is built up, what treatment costs and which of the two semaglutide injections fits which situation.
Ozempic contains semaglutide and is made by the Danish manufacturer Novo Nordisk. The European medicines authority EMA approved it in 2018 – for the treatment of type 2 diabetes. Because patients lost remarkable amounts of weight during therapy, the same active ingredient was later approved at a higher dose specifically for weight management: as Wegovy.
In practice, doctors sometimes prescribe Ozempic off-label – outside its approved indication – for weight reduction. That is legally permissible, but it should always follow an individual medical assessment and a documented rationale.
Ozempic is injected once a week under the skin – the day of the week can be freely chosen and should be kept consistent. The dose is increased step by step to limit nausea:
How long and at what level the dose is maintained is decided individually by the treating medical team – based on blood glucose, tolerability and weight-loss progress.
For diabetes, the SUSTAIN trial programme showed clear improvements in blood glucose and weight. The large weight-loss figures, however, come from the STEP studies using the higher-dosed Wegovy: participants on 2.4 mg semaglutide weekly lost on average about 15 % of their body weight over 68 weeks – placebo participants only about 2–3 %. NEJM: STEP 1 (2021).
If you are paying out of pocket, expect roughly 300–450 € per month, depending on dose and pharmacy. Statutory health insurance only covers the approved diabetes indication and subject to strict conditions – it normally does not pay for weight loss alone.
Both products contain semaglutide. The difference lies in dose and approval: Ozempic is approved for type 2 diabetes (up to 2.0 mg), Wegovy for weight management (up to 2.4 mg). If you want to lose weight and do not have a diabetes diagnosis, Wegovy is usually the medically cleaner choice. Details are on our Wegovy page and in the full comparison of all weight-loss injections.
Yes, as off-label use after medical review. That is legally permitted but not the approved indication. A version specifically approved for weight management exists: Wegovy.
The appetite-suppressing effect often sets in within the first days. Visible weight changes typically appear within 8 to 12 weeks, once the dose is sufficiently titrated.
Roughly 300 to 450 € for self-payers, depending on dose and pharmacy. Insurance only covers the diabetes indication under its own conditions.
No. Both contain the same active ingredient at different doses – combining them would amount to an overdose.
That varies individually. Studies show that weight often returns after stopping without further measures. The treatment duration should be agreed with your medical team.